← All drugs Report issue

tutocain

Small moleculemarketed

Approved

Jul 1, 1924

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Timeline

1920s

Jul 1, 1924
Evidence of US Marketing

Indications

Approved for

Anesthesia (approved 1924)

Mechanism of action

Sodium channel protein type III alpha subunitANTAGONIST
SCN3A antagonist
- Sodium channel protein type 3 subunit alpha (SCN3A) ↗

Approval history

approvedJul 1, 1924

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

tutocain